China biotech Epigenic raises $60M to test CRISPR epigenetic therapiesnews2025-09-08T02:00:04+00:00September 8th, 2025|Endpoints News|
#WCLC25: Merck and Daiichi Sankyo head to FDA with ADC for small cell lung cancernews2025-09-07T21:31:10+00:00September 7th, 2025|Endpoints News|
#WCLC25: Summit reports full Phase 3 data from first group of Western lung cancer patientsnews2025-09-07T07:30:43+00:00September 7th, 2025|Endpoints News|
Maraganore, Meanwell team up; FDA publishes CRLs; Endpoints 11: Where are they now?; and morenews2025-09-06T10:00:53+00:00September 6th, 2025|Endpoints News|
FDA chief says agency is probing Covid-19 vaccine deaths in kidsnews2025-09-05T19:30:39+00:00September 5th, 2025|Endpoints News|
FDA is readying more surprise inspections for foreign drug sites, Makary saysnews2025-09-05T17:36:12+00:00September 5th, 2025|Endpoints News|
Rapafusyn Pharmaceuticals’ $44M raise; CAGE Bio’s atopic dermatitis datanews2025-09-05T14:19:49+00:00September 5th, 2025|Endpoints News|
Regenxbio trumpets one-year data for Hunter syndrome gene therapy after FDA extended its reviewnews2025-09-05T14:14:19+00:00September 5th, 2025|Endpoints News|
Japan-made generic drugs will be exempt from Trump’s reciprocal tariff news2025-09-05T13:34:38+00:00September 5th, 2025|Endpoints News|
WHO adds GLP-1s to essential medicines listnews2025-09-05T13:00:18+00:00September 5th, 2025|Endpoints News|
